NFKB1 and cancer: Compelling evidence shows that chemotherapeutic and radiation treatments of solid cancers in general, and prostate tumors in particular, activates NF-κB, a key transcription factor that plays a critical role in the development and progression of cancers and consequently aiding chemo and multi therapy drug resistance.